![Carl June](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Carl June
Directeur/Membre du Conseil chez
AC IMMUNE SA
Fortune : 178 348 $ au 31/08/2026
Profil
Carl H.
June is the founder of Dispatch Biotherapeutics, Inc., founded in 2022.
Dr. June is also the founder of Tmunity Therapeutics, Inc...
Dr. June is the Director at the American Association for Cancer Research since 2018.
Dr. June is the Director at The Parker Institute For Cancer Immunotherapy.
Dr. June is an Independent Director at AC Immune SA since 2020.
Dr. June is a Senior Advisor at Arsenal Capital Management LP.
Dr. June was an Advisor at Signature Capital LLC.
Dr. June was an Advisor at GBP Capital.
Dr. June earned a doctorate from Baylor College of Medicine in 1979.
Dr. June earned an undergraduate degree from the United States Naval Academy in 1975.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
AC IMMUNE SA 0,07% | 11/06/2026 | 67 556 ( 0,07% ) | 178 348 $ | 31/08/2026 |
Postes actifs de Carl June
| Sociétés | Poste | Début |
|---|---|---|
| AC IMMUNE SA | Directeur/Membre du Conseil | 20/11/2020 |
Tmunity Therapeutics, Inc.
 Tmunity Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company | Fondateur | - |
American Association for Cancer Research
 American Association for Cancer Research Miscellaneous Commercial ServicesCommercial Services Engages in research, education, communication and collaboration to prevent and cure cancer | Directeur/Membre du Conseil | 01/01/2018 |
The Parker Institute For Cancer Immunotherapy
 The Parker Institute For Cancer Immunotherapy Miscellaneous Commercial ServicesCommercial Services Operates cancer research | Directeur/Membre du Conseil | - |
Arsenal Capital Management LP
 Arsenal Capital Management LP Investment ManagersFinance Arsenal Capital invests in middle market companies located in the United States. The firm focuses on healthcare and industrial sectors. It participates in buyouts, add-on acquisitions and growth stage capital transactions. | Consultant / Advisor | - |
Dispatch Biotherapeutics, Inc.
 Dispatch Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops cancer therapies to harness the immune system | Fondateur | 01/01/2022 |
Anciens postes connus de Carl June
| Sociétés | Poste | Fin |
|---|---|---|
Signature Capital LLC
 Signature Capital LLC Investment ManagersFinance Signature invests in early-stage growth technology companies in the following areas: electronic equipment/devices, application-specific semiconductor products, telecommunications, medical/biotechnology (healthcare products or therapies), Internet businesses and technology based service companies. They look for companies that have a proprietary position in timely new products or services and serve a large, established market that will allow rapid scalability of revenue to over $100 million per year. The company must strong, visionary managers and be in a field with good valuations in the securities markets | Corporate Officer/Principal | - |
GBP Capital
 GBP Capital Investment ManagersFinance GBP Capital provides venture funding and assistance to early and mid-stage life science companies. They target companies with unique approaches to diagnostics, therapeutics and medical devices. GBP Capital focuses on investing in companies with technologies that leverage and build upon medical breakthroughs, as well as other major developments taking place within the life-sciences industry. | Private Equity Investor | - |
Formation de Carl June
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
68
Relations au 1er degré
10
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 10 |
|---|---|
AC Immune SA
 AC Immune SA Pharmaceuticals: MajorHealth Technology Manufactures precision medicines for neurodegenerative diseases | Health Technology |
Arsenal Capital Management LP
Arsenal Capital Management LP Investment ManagersFinance Arsenal Capital invests in middle market companies located in the United States. The firm focuses on healthcare and industrial sectors. It participates in buyouts, add-on acquisitions and growth stage capital transactions. | Finance |
Signature Capital LLC
Signature Capital LLC Investment ManagersFinance Signature invests in early-stage growth technology companies in the following areas: electronic equipment/devices, application-specific semiconductor products, telecommunications, medical/biotechnology (healthcare products or therapies), Internet businesses and technology based service companies. They look for companies that have a proprietary position in timely new products or services and serve a large, established market that will allow rapid scalability of revenue to over $100 million per year. The company must strong, visionary managers and be in a field with good valuations in the securities markets | Finance |
United States Naval Academy
 United States Naval Academy Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Baylor College of Medicine
 Baylor College of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
American Association for Cancer Research
American Association for Cancer Research Miscellaneous Commercial ServicesCommercial Services Engages in research, education, communication and collaboration to prevent and cure cancer | Commercial Services |
GBP Capital
GBP Capital Investment ManagersFinance GBP Capital provides venture funding and assistance to early and mid-stage life science companies. They target companies with unique approaches to diagnostics, therapeutics and medical devices. GBP Capital focuses on investing in companies with technologies that leverage and build upon medical breakthroughs, as well as other major developments taking place within the life-sciences industry. | Finance |
Tmunity Therapeutics, Inc.
Tmunity Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company | Commercial Services |
The Parker Institute For Cancer Immunotherapy
The Parker Institute For Cancer Immunotherapy Miscellaneous Commercial ServicesCommercial Services Operates cancer research | Commercial Services |
Dispatch Biotherapeutics, Inc.
Dispatch Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops cancer therapies to harness the immune system | Health Technology |
